Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Differential immune responses between mothers and their infants to SARS-CoV-2
From the Overbaugh and Lehman Groups, Human Biology Division
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant
Study involving 22 U.S. cancer centers and research institutions is one of the largest analyses of vaccination for any pathogen within the first year after bone marrow transplant
Is the microbiome a springboard or barrier to effective vaccination?
From the Kublin Lab, Vaccine and Infectious Disease Division
Leveling up SARS-CoV-2 neutralization assays
From the Bloom Lab, Basic Sciences and Public Health Sciences Divisions
Learning from the past to improve SARS-CoV-2 variant discovery
From Dr. Lue Ping Zhao and collaborating labs, Public Health Sciences, Clinical Research, and Vaccine and Infectious Disease Divisions
The impact of antibodies to other coronaviruses on risk of SARS-CoV-2 infection in mothers and infants
From the Lehman and Overbaugh Labs, Human Biology Division
Community virus surveillance can double the data of vaccine trials
From Mr. Craig Magaret, Vaccine and Infectious Disease Division
Tracking SARS-CoV-2 evolution one infection at a time
From the Bloom Lab, Basic Sciences Divisions, and the Greninger and Jerome Labs, Vaccine and Infectious Disease Division
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation
NIAID director’s determined spirit recognized with honorary Hutch Award
Are revisions to remdesivir dosing needed for treating SARS-CoV-2?
From the Schiffer lab, Clinical Research and Vaccine and Infectious Disease Divisions
Drug identified to combat Omicron-induced cytokine storm
From the Gujral Lab, Human Biology Division
A bit of hit and miss – how well antibody responses in pre-clinical models resemble human responses
From the Overbaugh Lab, part of the Human Biology Division
The evolving landscape of sarbecovirus ACE2 binding
From the Bloom lab, Basic Sciences and Public Health Sciences Divisions
Antivirals have untapped potential in reducing SARS-CoV-2 related deaths
From the Brown and Janes labs, Public Health Sciences and Vaccine and Infectious Disease Divisions
Discovering potential emerging SARS-CoV-2 variants
From the Zhao, Gilbert, Geraghty and Jerome labs, a collaboration between Public Health Sciences, Vaccine and Infectious Disease, and the Clinical Research Divisions
SARS-CoV-2 mutations associated with COVID-19 related hospitalizations
From the Quantitative Genetic Epidemiology Group, Jerome Lab, and Geraghty Lab. A collaboration between the Clinical Research, Public Health Sciences, and Vaccine and Infectious Disease Divisions.
Tip Sheet: Fred Hutch experts tackle long COVID, improving outcomes for leukemia patients – and tips on staying healthy
Summaries of recent Fred Hutch research findings and other news
Tackling the unknowns of long-haul COVID-19
Fred Hutch and UW researchers are working together to better understand and treat the syndrome
Tip Sheet: New findings on immune response to COVID-19, new research from San Antonio Breast Cancer Symposium — and Fred Hutch expert predictions for 2022
Summaries of recent Fred Hutch research findings and other news
Sleuthing the immune system’s mysterious T-regs
Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around